Dragan Stajić

Dr. Dragan Stajić


Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 July 2024 in Medicina
Verified
Journal Article
Open access
PDF file
SMStevan Milatović
Stevan Milatović
AKAnita Krsman
Anita Krsman
BBBranislava Baturan
Branislava Baturan
ĐDĐorđe Dragutinović
Đorđe Dragutinović
DIDjordje Ilic
Djordje Ilic
DSDragan Stajić
Dragan Stajić
Background and Objectives: The incidence of labor induction is steadily increasing worldwide. The main aim of this study was to evaluate the ultrasound parameters and their mutual correlation and to analyze the parameters’ predictive capability in assessing the success of labor induction. The secondary goal was to assess patients’ tolerability and acceptance of transvaginal ultrasound and digital gynecological examination. Materials and Methods: This prospective observational follow-up study included 252 women selected for labor induction. The transvaginal ultrasound examination measured the posterior cervical angle, cervical length, the length and width funneling of the cervix, the distance between the head of the fetus and the external uterine os, and the position of the fetal occiput. After the ultrasound, a digital vaginal examination was performed (according to the Bishop score), and the women were asked to rate their perception of pain for each procedure. Results: The most common indication for labor induction was post-term pregnancy (57.59%), and the most common method of labor induction was oxytocin with amniotomy (70%). The results showed that a significant independent prediction of vaginal delivery could be provided based on the Bishop score and cervical length. Other investigated ultrasound parameters, the length and width of the funneling of the cervix (p < 0.001), the fetal head stage (p < 0.001), and the size of the posterior cervical angle (p < 0.05), showed statistical significance in relation to the success of labor induction. Patients reported lower discomfort and pain during transvaginal ultrasound examination (mean score 2, IQR 3) compared to digital examination (mean score 5, IQR 4), with p < 0.001. Conclusions: The results imply that the assessment of ultrasound parameters before induction of labor is necessary to predict the outcome and reduce the possibility of complications. In terms of tolerability and choice by the patients, the transvaginal ultrasound examination was better rated than the vaginal gynecological examination.

1 January 2021 in Srpski arhiv za celokupno lekarstvo
Verified
Journal Article
Open access
PDF file
DSDragan Stajić
Dragan Stajić
BGBorislav Golijan
Borislav Golijan
AMAljosa Mandic
Aljosa Mandic
SMSlobodan Maricic
Slobodan Maricic
This paper seeks to present surgical procedures, results and complications of treatment of verrucous carcinoma (VC) of the vulva treated in at Gynecological and Obstetric Clinics within the Faculty of Medicine, University of Novi Sad (Serbia), as well as literature review of surgical treatment of VC. During the period of 15 years (2005 to 2019), we performed 76 surgeries of vulvar cancer, 9 (11.8%) due to VC of the vulva. In surgical treatment of VC vulva, we performed complete surgical excision of the tumor (3), complete surgical excision of the tumor with defect coverage using VY fasciocutaneous skin flap (2), simplex vulvectomy (2), radical hemivulvectomy (1) and radical vulvectomy (1). We came across 2 main complications (22.2%): suture bleeding within 12 hours after excision in 1 patient (11.1%) and lower extremity lymphoedema after inguinofemoral lymphadenectomy with ligation of the great saphenous vein in 1 patient (11.1%). In total number of 9 treated patients survival rate was 88.8% (8 patients) with death rate of 11.1% (1 patient) within 12 months after surgery. In 3 patients (33.3%) after surgery, the disease returned: 1 - residual tumor after surgery, 1 - relapse on the other side 1 year after surgery, 1 - newly developed invasive squamous cell carcinoma 10 years after primary surgery.

5 June 2026 in Preprints.org
Verified
Preprint
Open access
PDF file
DSDragan Stajić
Dragan Stajić
MBMirjana A. Bogavac
Mirjana A. Bogavac
MSMarko Sinisa Stojic
Marko Sinisa Stojic
GNGabriel-Stefan Nadj
Gabriel-Stefan Nadj
MIMarko Ilinčić
Marko Ilinčić
Jovana MiskovicJovana Miskovic
Jovana Miskovic
Pregnancy involves profound metabolic, hormonal, and immunological adaptations essential for fetal development; however, disturbances may lead to complications such as preeclampsia (PE), pre-gestational diabetes, and gestational diabetes mellitus (GDM). These conditions are closely linked to oxidative stress, inflammation, endothelial dysfunction, impaired placentation, and metabolic dysregulation. Consequently, dietary strategies capable of modulating these pathways are of increasing interest. Edible and medicinal mushrooms have emerged as functional foods rich in bioactive compounds with antioxidant, anti-inflammatory, immunomodulatory, and metabolic regulatory effects. This review summarizes the nutritional composition of mushrooms and highlights key bioactive constituents, such as ergothioneine, which may influence redox balance, immune responses, glucose metabolism, endothelial function, and placental development. Experimental evidence suggests that these compounds modulate pathways involved in PE and GDM pathogenesis. Mushroom consumption has additionally been associated with improved glycemic control, enhanced antioxidant defenses, and reduced risk of hypertensive and metabolic pregnancy complications. Although preclinical findings are promising, clinical evidence remains limited. Further well-designed prospective studies and randomized controlled trials are required to determine efficacy, safety, optimal intake, and active compounds responsible for these effects. Nevertheless, current evidence supports edible and medicinal mushrooms as potential dietary modulators of key mechanisms involved in PE and GDM, with relevance for improving maternal-fetal health outcomes.

3 July 2026 in Molecules
Verified
Journal Article
Open access
PDF file
DSDragan Stajić
Dragan Stajić
MBMirjana A. Bogavac
Mirjana A. Bogavac
MSMarko Sinisa Stojic
Marko Sinisa Stojic
GNGabriel-Stefan Nadj
Gabriel-Stefan Nadj
MIMarko Ilinčić
Marko Ilinčić
Jovana MiskovicJovana Miskovic
Jovana Miskovic
Pregnancy involves profound metabolic, hormonal, and immunological adaptations essential for fetal development; however, disturbances may lead to complications such as preeclampsia (PE), pre-gestational diabetes, and gestational diabetes mellitus (GDM). These conditions are closely linked to oxidative stress, inflammation, endothelial dysfunction, impaired placentation, and metabolic dysregulation. Consequently, dietary strategies capable of modulating these pathways are of increasing interest. Edible and medicinal mushrooms are widely studied as functional food due to the content of bioactive compounds with antioxidant, anti-inflammatory, immunomodulatory, and metabolic regulatory effects. This review summarizes the nutritional composition of mushrooms and highlights key bioactive constituents with antioxidant and metabolic regulatory properties. Among them, ergothioneine has emerged as a key molecule due to its potent redox-buffering capacity and its potential involvement in the activation of the Nrf2 signaling pathway, a master regulator of cellular antioxidant defense. Through modulation of Nrf2-dependent gene expression, mushroom-derived compounds may contribute to improved cellular resilience against oxidative damage relevant to PE and GDM pathophysiology. Mushroom consumption has additionally been associated with improved glycemic control and enhanced antioxidant defenses in experimental and limited clinical studies, although evidence regarding the prevention or management of hypertensive and metabolic pregnancy complications remains insufficient. Although preclinical findings are promising, clinical evidence remains limited. Further well-designed prospective studies and randomized controlled trials are required to determine efficacy, safety, optimal intake, and active compounds responsible for these effects. Nevertheless, current evidence supports the biological plausibility that edible and medicinal mushrooms are promising dietary modulators of the ergothioneine–Nrf2 axis with potential relevance for maternal–fetal health.

22 August 2026 in Medicina
Verified
Journal Article
Open access
PDF file
ANAleksandra Nikolić
Aleksandra Nikolić
MBMirjana A. Bogavac
Mirjana A. Bogavac
NKNebojša Kladar
Nebojša Kladar
DSDragan Stajić
Dragan Stajić
KKKatarina Kovacevic
Katarina Kovacevic
AKAnita Krsman
Anita Krsman
Background and Objectives: Pre-eclampsia (PE) is an obstetric complication defined by placental insufficiency, including intrauterine growth restriction and placental abruption. Timely and accurate detection and treatment of pre-eclampsia are difficult because its diagnostic criteria are still based on nonspecific signs and symptoms and because the association between common severity criteria, and unfavorable outcomes for mother and fetus remain unclear. Therefore, the aim of this study was to evaluate the potential use of blood and urine PE risk markers—soluble Fms-like tyrosine kinase-1 (sFlt-1), placental growth factor (PlGF), sFlt-1/PlGF ratio, and albumin/creatin ratio—in predicting and managing PE in groups at risk for preterm and term PE (gestational weeks 24–37) and to correlate the levels of blood and urine PE markers with pregnancy outcome indicators. Materials and Methods: This study was conducted at the Department of Obstetrics and Gynecology and at the Center of Laboratory Diagnostics and Nuclear Medicine, University Clinical Center of Vojvodina. This study included 166 pregnant women (GW 24–37) divided into two groups: study group P (n = 52), consisting of pregnant women who were identified as a high-risk group for PE according to clinical signs and medical history and who subsequently developed PE; control group C (n = 114), consisting of pregnant women who had risk factors in their medical history but did not eventually develop PE symptoms. The evaluated parameters included two groups: blood and urine PE risk indicators—biochemical markers such as PlGF, sFlt-1, and sFlt-1/PlGF ratio; urine risk indicators such as albumin/creatine ratio; and pregnancy outcome indicators—gestational age of delivery (GW) and neonatal birth weight (NW). Results: The results of the analysis support that the PE risk biochemical indicators (PlGF, sFlt-1, sFlt-1/PlGF ratio, and albumin/creatine ratio) show statistically significant differences between the analyzed groups, that they correlate with PE occurrence, and that they have good predictive value. As expected, sFlt-1/PlGF ratio and albumin/creatine ratio, as the most valuable PE risk indicators, show good predictive value. However, our results also demonstrate that pro- and antiangiogenic indicators alone, especially sFlt-1 (high values), may play roles in risk evaluation and prediction of preterm and term PE (GW 24–37). Conclusions: In our study, all evaluated blood and urine indicators (PlGF, sFlt-1, sFlt-1/PlGF ratio, and albumin/creatine ratio) show high predictive value for PE in a PE risk group of pregnancies between GW 24 and 37. The results suggest that sFlt-1 alone has equal predictive value to sFlt-1/PlGF ratio and outperformed PlGF in predicting PE onset. The combined use of pro- and antiangiogenic biochemical markers, indices, and urine markers in blood, together with patient history and clinical parameters, shows potential as a more effective means of predicting PE than a single biochemical parameter such as sFlt-1/PlGF ratio.